🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate, in healthy adult volunteers, the safety and immunogenicity of ...
Status
Completed
Location
Johns Hopkins Univ / Ctr for Immunological Research
Start Date
TBD
Trial ID
NCT00000795
Treatments Being Tested
The purpose of this study is to find and confirm the dose and asses the rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-04-27
Trial ID
NCT05823974
This phase 2B, placebo-controlled, randomized, observer-blinded trial will ...
Status
Completed
Location
Alliance for Multispecialty Research, LLC
Start Date
2022-08-12
Trial ID
NCT04766086
Observer-blind, partially randomized, multi-center dose escalation Phase I ...
Status
Completed
Location
eStudy Site
Start Date
2017-01-31
Trial ID
NCT03010228
Treatments Being Tested
The purpose of this study is to learn about the safety, tolerability and im...
Status
Completed
Location
Emerson Clinical Research Institute
Start Date
2024-07-30
Trial ID
NCT06531538
Treatments Being Tested
The purpose of this study is to learn about the safety and tolerability of ...
Status
Active Not Recruiting
Location
Orange County Research Center
Start Date
2025-07-22
Trial ID
NCT07086677
The purpose of this study is to evaluate the safety and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00520598
The purpose of this study is to assess the safety and immune response of Gl...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-05-23
Trial ID
NCT06431607
This is a Phase 1, single-centre, randomised, placebo-controlled first in h...
Status
Completed
Location
Hammersmith Medicines Research (HMR)
Start Date
2021-10-12
Trial ID
NCT05093530
This is a randomized, observer-blind, placebo controlled, multicenter Phase...
Status
Completed
Location
Clinical Research Consulting, LLC
Start Date
2018-12-17
Trial ID
NCT03769194